QDEL
QuidelOrtho Corporation
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
14.27
▼ 0.58 (3.91%)
MARKET · —
Price
Open
14.80
Prev close
14.85
Day high
15.50
Day low
14.11
Volume
1.99M
Market cap
$1.01B
P/E (TTM)
—
52W range
9.92 – 35.58
Trailing performance
Returnvs SPY
1W
+3.08%
+4.4%
1M
-11.10%
-14.8%
3M
+18.97%
+15.9%
6M
-34.43%
-45.5%
YTD
-48.39%
-60.7%
1Y
-44.04%
-64.0%
3Y
-79.52%
-153.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$1.01B
Enterprise value$3.96B
Revenue (TTM)$2.67B
Gross profit$1.20B
EBITDA$484.60M
Net income$-1.05B
EPS (TTM)$-15.43
Free cash flow$146.76M
Total cash$123.40M
Total debt$3.08B
Book value / share$25.99
Shares outstanding68.58M
Float61.17M
Short % of float25.85%
Dividend yield—
Beta (5Y)0.69
Valuation & profitability ratios
Trailing P/E—
Forward P/E10.04
PEG ratio2.06
Price / sales—
Price / book0.57
EV / revenue1.48
EV / EBITDA8.18
Gross margin44.86%
Operating margin-2.09%
Profit margin-39.20%
Return on equity-45.91%
Return on assets0.38%
Debt / equity173.28
Current ratio1.39
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $2.73B | $2.78B | $3.00B | $3.27B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$1.13B | -$2.03B | -$10.10M | $548.70M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$1.13B | -$2.03B | -$10.10M | $548.70M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.05 | 0.13 | +374.6% |
| Mar 2026 | 0.36 | -0.04 | -111.2% |
| Dec 2025 | 0.42 | 0.46 | +8.8% |
| Sep 2025 | 0.47 | 0.80 | +71.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.18 | 1 | $628.07M | -10.3% |
| Next quarter | 0.47 | 1 | $665.60M | -8.0% |
| Current year | 0.78 | 2 | $2.54B | -6.8% |
| Next year | 1.44 | 2 | $2.59B | +1.9% |
Analyst targets & ownership
Mean target$14.67
High target$20.00
Low target$12.00
Implied upside2.78%
Analyst count3
ConsensusHOLD
Strong buy / Buy0 / 1
Hold1
Sell / Strong sell0 / 1
Held by insiders0.89%
Held by institutions124.86%
Institutions holding340
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
613.06K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | HANSON BRYAN MICHAEL Officer |
— | 446 | — | Direct |
| Jul 1, 26 | HANSON BRYAN MICHAEL Officer |
— | 5.80K | — | Direct |
| Jun 5, 26 | POLAN MARY LAKE PH.D Director |
CONVERSION | 749 | $10.73K | Direct |
| Jun 5, 26 | WIDDER KENNETH JON M.D. Director |
CONVERSION | 910 | $13.04K | Direct |
| Jun 5, 26 | BUECHLER KENNETH F Director |
CONVERSION | 1.66K | $23.77K | Direct |
| Jun 5, 26 | MICHAEL EDWARD L Director |
CONVERSION | 963 | $13.80K | Direct |
| Jun 5, 26 | POLAN MARY LAKE PH.D Director |
STOCK | 973 | $0 | Direct |
| Jun 5, 26 | WIDDER KENNETH JON M.D. Director |
STOCK | 1.18K | $0 | Direct |
| Jun 5, 26 | MICHAEL EDWARD L Director |
STOCK | 1.25K | $0 | Direct |
| Jun 5, 26 | BUECHLER KENNETH F Director |
STOCK | 2.16K | $0 | Direct |
| May 29, 26 | POLAN MARY LAKE PH.D Director |
CONVERSION | 6.83K | $88.91K | Direct |
| May 29, 26 | WIDDER KENNETH JON M.D. Director |
CONVERSION | 6.83K | $88.91K | Direct |
| May 29, 26 | WILKINS JOSEPH D JR Director |
CONVERSION | 6.83K | $88.91K | Direct |
| May 29, 26 | CHIMINSKI JOHN R Director |
CONVERSION | 6.83K | $88.91K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLASER BRIAN J |
Chief Executive Officer | 75.72K | Conversion of Exercise of derivative security |
BUECHLER KENNETH F |
Director | 110.91K | Conversion of Exercise of derivative security |
BUJARSKI ROBERT JOSEPH |
Chief Operating Officer | 44.81K | Conversion of Exercise of derivative security |
BUSKY JOSEPH M |
Chief Financial Officer | 55.11K | Conversion of Exercise of derivative security |
HODGES MICHELLE A |
Officer | 41.60K | Conversion of Exercise of derivative security |
MICHAEL EDWARD L |
Director | 29.43K | Conversion of Exercise of derivative security |
POLAN MARY LAKE PH.D |
Director | 37.80K | Conversion of Exercise of derivative security |
RHOADS ANN D |
Director | 23.26K | Conversion of Exercise of derivative security |
STROBECK MATTHEW |
Director | 89.38K | Conversion of Exercise of derivative security |
WIDDER KENNETH JON M.D. |
Director | 45.07K | Conversion of Exercise of derivative security |
Moving averages & technicals
SMA 10
14.34
-0.46% from price
SMA 20
15.40
-4.32% from price
SMA 50
15.75
-6.41% from price
SMA 100
14.40
-0.87% from price
SMA 200
19.85
-25.75% from price
EMA 12
14.73
-3.11% from price
EMA 26
15.26
-6.52% from price
EMA 50
15.40
-7.35% from price
RSI (14)
46.9
Neutral
MACD (12,26,9)
-0.54
Hist -0.09
ATR (14)
1.47
9.97% of price
Realised vol 30D
104.4%
Annualised
Bollinger upper
18.48
20, 2σ
Bollinger lower
12.33
20, 2σ
50 / 200 cross
Death
15.75 vs 19.85
Trend bias
Below 200
-25.75%
Risk profile
Beta vs SPY
2.46
More volatile than market
Correlation to SPY
0.35
Loosely linked
Realised vol 30D
104.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-71.8%
Peak to trough
Max drawdown 5Y
-94.3%
Peak to trough
ATR 14
1.47
9.97% of price
Beta (reported)
0.69
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
1.41
Put-heavy session
Put / call open interest
1.08
Positioning, not flow
Max pain
17.50
+18.7% from spot
ATM implied vol
79.3%
Nearest strike to spot
Skew (10% OTM)
-3.5%
Calls bid over puts
Call volume
135
Contracts, this expiry
Put volume
190
Contracts, this expiry
Heaviest call OI
20.00
1.45K contracts
Heaviest put OI
12.50
2.03K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
3 Unprofitable Stocks with Warning Signs
StockStory · 1d ago
QuidelOrtho (QDEL) Is Up 6.0% After Cutting 2026 Revenue Outlook Amid Narrowing Losses – What's Changed
Simply Wall St. · 5d ago
QDEL's 2026 Outlook Cut Deepens China and Respiratory Risk Concerns
Zacks · 5d ago
Is QDEL Worth Buying as China Risks Clash With Resilient Core Growth?
Zacks · 5d ago
QDEL Rallies 31.7% in Three Months: Can the Stock Keep Climbing Higher?
Zacks · 5d ago
Healthcare Equipment and Supplies Stocks Q2 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers
StockStory · 5d ago
The 5 Most Interesting Analyst Questions From QuidelOrtho’s Q2 Earnings Call
StockStory · 7d ago
QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcript
Motley Fool · 9d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.